Protected 1,2-Amino Alcohols Asymmetric Synthesis
J . Org. Chem., Vol. 66, No. 26, 2001 8777
5H), 1.50-1.64 (m, 2H), 3.19-3.28 (m, 1H), 3.54-3.60 (m, 2H),
3.71-3.74 (m, 2H), 3.75-3.77 (m, 1H); 13C NMR (100 MHz) δ
-5.61, -5.48, 13.89, 18.09, 22.50, 22.54, 25.73, 27.73, 32.01,
55.43, 56.91. Anal. Calcd for C16H37NO2SSi: C, 57.26; H, 11.11;
N, 4.17. Found: C, 56.99; H, 11.21; N, 4.10.
0.07 (s, 3H), 0.91 (s, 9H), 1.23 (s, 9H), 3.59-3.64 (m, 1H), 3.78
(dd, 1H, J ) 10.1, 4.1), 4.29 (m, 1H), 4.51-4.55 (m, 1H), 7.28-
7.36 (m, 5H); 13C NMR (100 MHz) δ -5.61, -5.42, 18.07, 22.47,
25.72, 55.23, 59.25, 67.76, 110.40, 127.95, 128.32, 138.45. Anal.
Calcd for C18H33NO2SSi: C, 60.79; H, 9.35; N, 3.94. Found:
C, 60.40; H, 9.58; N, 3.73.
Absolute determination was determined through deprotec-
tion of 4e, affording (R)-phenylglycinol: [R]23D ) -29.1 (c )
0.750, 1.00 N HCl) [lit.: [R]23D ) -26.7 (c ) 0.075, 1.00 N
HCl)].9
(RS,1R)-2-Meth ylp r op a n e-2-su lfin ic Acid [1-((ter t-Bu t-
yldim eth ylsilan yloxy)m eth yl)-2-m eth ylpr opyl]am ide (4c).
The general procedure was followed with 52 mg of 2 (0.19
mmol), 1.0 mL of toluene, and 0.15 mL of i-PrMgCl (2.0 M
solution in Et2O, 0.29 mmol). Pure 4c (53 mg, 88%) was
obtained as a clear, colorless oil after column chromatography
(20% EtOAc/Hex to 60% EtOAc/Hex), with a dr (crude) of 96:
4: HPLC-MS (70-95% MeOH/H2O over 10 min at 1 mL/min)
tR(major) ) 12.63 min, tR(minor) ) 12.12 min; [R]23D ) -37.1
(RS,1S)-2-Met h ylp r op a n e-2-su lfin ic Acid (1-(Ben zyl-
oxym eth yl)-1-m eth ylp en tyl)a m id e (7a ). Pure 7a was ob-
tained as a clear, colorless oil after column chromatography
(50% EtOAc/Hex to 70% EtOAc/Hex) with yields and diaste-
reoselectivities given in Table 4. (Diastereomeric ratio deter-
mined through comparison of integration of doublets (major)
at 3.26 and 3.40 ppm with doublet at 3.34 ppm: [R]23D ) -57.1
(c ) 1.00, CHCl3); IR 1069 cm-1; 1H NMR (400 MHz) δ 0.90 (t,
3H, J ) 6.9), 1.18-1.19 (m, 12H), 1.21-1.34 (m, 4H), 1.68-
1.72 (m, 2H), 3.26 (d, 1H, J ) 8.9), 3.40 (d, 1H, J ) 8.9), 3.61
(s, 1H), 4.50 (d, 1H, J ) 12), 4.55 (d, 1H, J ) 12), 7.26-7.36
(m, 5H); 13C NMR (100 MHz) δ 13.96, 22.51, 23.04, 23.08,
25.85, 37.80, 55.39, 58.03, 73.10, 76.83, 127.46, 127.49, 128.22,
138.23. Anal. Calcd for C18H31NO2S: C, 66.42; H, 9.60; N, 4.30.
Found: C, 66.60; H, 9.49; N, 4.19.
(RS,1S)-2-Meth ylp r op a n e-2-su lfin ic Acid (2-Ben zyloxy-
1-m eth yl-1-p h en yleth yl)a m id e (7b). Pure 7b was obtained
as a clear, colorless oil after column chromatography (50%
EtOAc/Hex to 70% EtOAc/Hex) with yields and diastereose-
lectivities given in Table 4: HPLC-MS (60.0-97.5% MeOH/
H2O over 20 min at 1 mL/min) tR(major) ) 11.36 min, tR(minor)
) 11.69 min; [R]23D ) -30.9 (c ) 1.00, CHCl3); IR 1068, 1602
cm-1; 1H NMR (400 MHz) δ 1.21 (s, 9H), 1.64 (s, 3H), 3.76 (d,
1H, J ) 9.0), 3.87 (d, 1H, J ) 9.0), 4.09 (d, 1H, J ) 2.8), 4.51
(d, 1H, J ) 12), 4.59 (d, 1H, J ) 12), 7.26-7.43 (m, 8H), 7.49-
7.51 (m, 2H); 13C NMR (100 MHz) δ 22.58, 26.54, 55.87, 60.75,
73.20, 77.53, 126.65, 127.22, 127.50, 127.55, 128.12, 128.24,
137.99, 143.48. Anal. Calcd for C20H27NO2S: C, 69.53; H, 7.88;
N, 4.05. Found: C, 69.37; H, 7.94; N, 3.89.
(c ) 1.00, CHCl3); IR 1077, 1104, 1472 cm-1 1H NMR (400
;
MHz) δ 0.04 (s, 3H), 0.05 (s, 3H), 0.87 (s, 9H), 0.87-0.90 (m,
6H), 1.20 (s, 9H), 1.87-1.94 (m, 1H), 2.93-3.01 (m, 1H), 3.69
(d, 1H, J ) 7.9), 3.73 (d, 2H, J ) 4.5); 13C NMR (100 MHz) δ
-5.65, -5.55, 18.02, 18.51, 18.94, 22.62, 25.70, 29.51, 55.69,
62.63, 63.51. Anal. Calcd for C15H35NO2SSi: C, 56.02; H, 10.97;
N, 4.36. Found: C, 55.97; H, 10.99; N, 4.29.
(RS,R)-2-Meth ylp r op a n e-2-su lfin ic Acid [1-((ter t-Bu t-
yld im eth ylsila n yloxy)m eth yl)-2,2-d im eth ylp r op yl]a m id e
(4d ). The general procedure was followed with 52 mg of 2 (0.19
mmol), 1.0 mL of toluene, and 0.15 mL of t-BuMgCl (2.0 M
solution in Et2O, 0.29 mmol). Pure 4d (57 mg, 90%) was
obtained as a clear, colorless oil after column chromatography
(20% EtOAc/Hex to 60% EtOAc/Hex), with a dr (crude) of 96:
4: HPLC-MS (70-95% MeOH/H2O over 10 min at 1 mL/min)
tR(major) ) 13.38 min, tR(minor) ) 12.50 min; [R]23D ) -80.8
(c ) 1.00, CHCl3); IR 1077, 1111, 1472 cm-1 1H NMR (400
;
MHz) δ 0.05 (s, 3H), 0.06 (s, 3H), 0.88 (s, 9H), 0.92 (s, 9H),
1.23 (s, 9H), 2.84-2.87 (m, 1H), 3.77 (dd, 1H, J ) 10.3, 4.2),
3.94 (dd, 1H, J ) 10.3, 1.8), 4.10 (d, 1H, J ) 7.5); 13C NMR
(100 MHz) δ -5.71, -5.67, 17.93, 22.78, 25.70, 27.27, 35.17,
55.91, 63.29, 64.91. Anal. Calcd for C16H37NO2SSi: C, 57.26;
H, 11.11; N, 4.17. Found: C, 57.14; H, 11.31; N, 4.09. Refer to
details for compound 10 for assignment of absolute configu-
ration.
Deter m in a tion of Absolu te Con figu r a tion of 7b. The
representative procedures were followed for conversion of
O-benzyl sulfinamides 7 to amino alcohols, affording (S)-2-
amino-2-phenylpropan-1-ol (8.6 mg, 70%): [R]23D ) +7.40 (c
) 0.500, EtOH) [lit.: [R]23D ) +14.3 (c ) 0.980, EtOH)].17
(RS,1S)-2-Meth ylp r op a n e-2-su lfin ic Acid [1-((ter t-Bu t-
yldim eth ylsilan yloxy)m eth yl)-1-m eth ylpr opyl]am ide (8a).
Pure 8a was obtained as a clear, colorless oil after column
chromatography (30% EtOAc/Hex to 70% EtOAc/Hex) with
yields and diastereoselectivities given in Table 5: HPLC-MS
(70-95% MeOH/H2O over 10 min at 1 mL/min) tR(major) )
10.45 min, tR(minor) ) 10.69 min; [R]23D ) -43.6 (c ) 1.00,
(RS,R)-2-Meth ylp r op a n e-2-su lfin ic Acid [1-((ter t-Bu t-
yldim eth ylsilan yloxy)m eth yl)-3-ph en ylpr op-2-yn yl]am ide
(4e). Phenylacetylmagnesium bromide was first prepared
according to a modified procedure by Poncini:19 To a 25 mL
Schlenk tube with sidearm under a N2 atmosphere was added
a solution of EtMgBr (0.32 mL, 0.97 mmol, 3.0 M) in Et2O. To
this solution was then added phenylacetylene (0.61 mL, 0.54
mmol). The valve was then closed and the tube heated to 60
˚C for 6 h. The valve was then opened and the solvent
evaporated under a stream of nitrogen for 45 min. To the
residue was added 1.5 mL of toluene and the suspension cooled
to -78 ˚C. To this mixture was added a solution of 2 (75 mg,
0.27 mmol) in 1.5 mL of toluene. Pure 4e (63 mg, 90%) was
obtained as a clear, colorless oil after column chromatography
(30% EtOAc/Hex to 60% EtOAc/Hex), with a dr (crude) of 90:
10: HPLC-MS (70-95% MeOH/H2O over 10 min at 1 mL/
CHCl3); IR 1077, 1463 cm-1 1H NMR (400 MHz) δ 0.06 (s,
;
3H), 0.06 (s, 3H), 0.86-0.94 (m, 3H), 0.90 s, 9H), 1.14 (s, 3H),
1.19 (s, 9H), 1.73 (q, 2H, J ) 7.4), 3.32 (d, 1H, J ) 9.4), 3.51
(d, 1H, J ) 9.4), 3.66 (s, 1H); 13C NMR (100 MHz) δ -5.76,
-5.72, 8.32, 18.08, 21.71, 22.52, 25.71, 30.61, 55.35, 58.77,
69.27. Anal. Calcd for C15H35NO2SSi: C, 56.02; H, 10.97; N,
4.36. Found: C, 55.98; H, 10.99; N, 4.30.
Deter m in a tion of Absolu te Con figu r a tion of 8a . The
general procedure was followed for conversion of TBS protected
sulfinamides 8 to amino alcohols, affording (S)-2-amino-2-
methylbutan-1-ol (9.1 mg, 74%): [R]23D ) -4.40 (c ) 0.500,
EtOH) [lit.: (R)-enantiomer [R]23D ) +3.40 (c not reported,
EtOH)].18
(RS,1S)-2-Meth ylp r op a n e-2-su lfin ic Acid [1-((ter t-Bu t-
yldim eth ylsilan yloxy)m eth yl)-1-m eth ylpen tyl]am ide (8b).
Pure 8b was obtained as a clear, colorless oil after column
chromatography (30% EtOAc/Hex to 70% EtOAc/Hex) with
yields and diastereoselectivities given in Table 5: HPLC-MS
(70-95% MeOH/H2O over 10 min at 1 mL/min) tR(major) )
11.55 min, tR(minor) ) 11.76 min; [R]23D ) -46.5 (c ) 1.00,
CHCl3); IR 1072, 1104, 1471 cm-1; 1H NMR (400 MHz) δ 0.05
(s, 3H), 0.06 (s, 3H), 0.90 (s, 9H), 0.90 (m, 3H), 1.19 (s, 9H),
1.24 (s, 3H), 1.29 (m, 2H), 1.66-1.70 (m, 4H), 3.32 (d, 1H, J )
9.4), 3.51 (d, 1H, J ) 9.4), 3.68 (s, 1H); 13C NMR (100 MHz) δ
1
min) tR(major) ) 9.982 min, tR(minor) ) 10.87 min; H NMR
(400 MHz) δ 0.09 (s, 3H), 0.10 (s, 3H), 0.91 (s, 9H), 1.24 (s,
9H), 3.70-3.77 (m, 1H), 3.80-3.87 (m, 2H), 7.27-7.30 (m, 3H),
7.40-7.44 (m, 2H); 13C NMR (100 MHz) δ -5.45, -5.39, 18.19,
22.49, 25.73, 50.03, 56.18, 66.86, 85.61, 86.44, 128.09, 128.14,
128.27, 131.68. Barrow et al. previously prepared this com-
pound.9
(RS,1R)-2-Meth ylp r op a n e-2-su lfin ic Acid [2-(ter t-Bu t-
yld im eth ylsila n yloxy)-1-p h en yleth yl]a m id e (4f). The gen-
eral procedure was followed with 52 mg of 2 (0.19 mmol), 1.0
mL of toluene, and 0.10 mL of PhMgBr (3.0 M solution in Et2O,
0.29 mmol). Pure 4f (63 mg, 95%) was obtained as a clear,
colorless oil after column chromatography (20% EtOAc/Hex to
60% EtOAc/Hex), with a dr (crude) of 96:4: HPLC-MS (60.0-
97.5% MeOH/H2O over 20 min at 1 mL/min) tR(major) ) 16.70
min, tR(minor) ) 16.45 min; [R]23D ) -111 (c ) 1.00, CHCl3);
IR 1069, 1077, 1630 cm-1; 1H NMR (400 MHz) δ 0.05 (s, 3H),
(19) Poncini, L. J . Org. Chem. 1984, 49, 2031-2032.